Guangzhou Pharmaceutical Holdings Limited (GPHL) is the leading company in promoting the strategy to thrive the traditional Chinese medicine in south China, with two listed companies—Guangzhou Pharmaceutical Company Limited and Guangzhou Baiyunshan Pharmaceutical Co., Ltd and 30+ subsidiaries with the core businesses of research and development, producing and selling chemical medicine, herbal medicine and bio-medicine.
In Y2011, GPHL achieved a sales revenue of RMB 33.078 billion, representing a year-on-year increase of 19.90%. Gross value of industrial output totaled to RMB 11.384 billion, representing a year-on-year increase of 16.54%. Total profit climbed by 32.4% to RMB 1.359 billion.
General Manager of GPHL—Li Chuyua had a discussion meeting with Vice chairman Xi Jinping on July 2, 2011